2,2, 4,4 - Tetrahydroxychalcone-2
2,2, 4,4 - Tetrahydroxychalcone-2
2,2, 4,4 - Tetrahydroxychalcone-2
Abstract − Tyrosinase is one of the important enzymes in the mammalian melanin synthesis. In the process of
melanin synthesis, tyrosine is oxidized to DOPA (3,4-dihydroxyphenylalanine), and DOPA is further oxidized to
dopaquinone. Tyrosinase is an enzyme catalyzing this oxidation of tyrosine, so chemicals that inhibit the activity
of tyrosinase can be used as skin whitening agents. In this study, we isolated five constituents from the 80%
MeOH extract of Morus bombycis cortex by bioactivity-guided fractionation. We performed mushroom tyrosinase
inhibition assay. As a result, 7,2',4'-trihydroxyflavanone (1), 2',4',2,4,-tetrahydroxychalcone (2), and oxyresveratrol
(3) showed the more potent inhibitory effect compared to kojic acid, a well-known skin whitening agent with anti-
tyrosinase effect. Moracinoside M (4) and moracin M-3'-O-β-D-glucopyranoside (5) also showed the moderate
tyrosinase inhibitory activities.
Keywords − Morus bombycis, skin whitening, tyrosine, tyrosinase inhibitory effect
198
Vol. 17, No. 3, 2011 199
5200 sonicator. MPLC was performed using Teledyne 2.3 Hz, H-6), 6.42 (1H, d, J = 1.9 Hz, H-3'), 6.39 (1H, dd,
CombiFLASH RETRIEVE using Teledyne Redisep Rf J = 2.3, 8.3 Hz, H-5'), 6.38 (1H, d, J = 2.3 Hz, H-8), 5.69
C18 reverse phase columns. Preparative HPLC was (1H, dd, J = 13.3, 2.7 Hz, H-2), 3.02 (1H, dd, J = 16.7,
performed using HITACHI L-7100 pump with HITACHI 15.4 Hz, H-3eq.), 2.65 (1H, dd, J = 16.7, 2.8 Hz, H-3ax.).
L-7420 UV detector and Phenomenex Hemini C18 5 µm 13
C-NMR (125 MHz, acetone-d6): δ 191.7 (C-4), 165.6
column (150 × 10 mm). ESI MS data were obtained on (C-9), 165.4 (C-7), 159.8 (C-4'), 156.6 (C-2'), 130.0 (C-
Agilent 1100 series LC/MSD trap LC/MS. NMR spectra 5), 129.4 (C-6'), 118.6 (C-1'), 115.6 (C-10), 111.5 (C-6),
were recorded on JEOL GSX 400 Spectrometer (400 108.3 (C-5'), 104.1 (C-8), 103.9 (C-3'), 76.3 (C-2), 44.2
MHz), JEOL LA 300 Spectrometer (300 MHz), and (C-3).
Bruker AMX 500 Spectrometer (500 MHz). All chemicals 2',4',2,4,-Tetrahydroxychalcone (2): C H O , colorless
15 12 6
for tyrosinase inhibition assay, including mushroom amorphous powder. ESI MS (m/z) : 271 [M-H]−. H- 1
tyrosinase, L-tyrosine, and kojic acid, were purchased NMR (500 MHz, CD OD): δ 8.09 (1H, d, J = 15.4 Hz, H-
3
from Sigma-Aldrich Chimical Co.. β), 7.88 (1H, d, J = 8.9 Hz, H-6), 7.70 (1H, d, J = 15.4
Plant Material − The cortex of Morus bombycis was Hz, H-α), 7.51 (1H, d, J = 8.4 Hz, H-6'), 6.39 (1H, dd,
collected in Nambu forest of Seoul National University, J = 2.3, 8.9 Hz, H-5), 6.36 (1H, dd, J = 2.2, 8,4 Hz, H-5'),
Baegwoon Mountain, Gwangyang city, Jeollanamdo, 6.34 (1H, d, J = 2.2 Hz, H-3'), 6.27 (1H, d, J = 2.3 Hz, H-
Korea, in September 2008. A voucher specimen (SNU- 3). C-NMR (125 MHz, CD OD): δ 194.9 (C = O),
13
3
0785) has been deposited in the Herbarium of the 168.1 (C-2), 166.9 (C-4), 163.6 (C-4'), 161.6 (C-2'), 142.9
Medicinal Plant Garden, College of Pharmacy, Seoul (C-β), 133.8 (C-6), 133.1 (C-6'), 118.4 (C-α), 116.4 (C-
National University. 1'), 115.6 (C-1), 109.9 (C-5'), 109.8 (C-5), 104.6 (C-3),
Extraction and Isolation − The air-dried cortex of 104.3 (C-3').
Morus bombycis (4.5 kg) was extracted with 80% MeOH Oxyresveratrol (3): C H O , colorless amorphous
15 12 6
in an ultrasonic apparatus at room temperature and 329.3 powder. ESI MS (m/z) : 243 [M-H]−. H-NMR (300 1
g of total extract was obtained. This extract was suspended MHz, CD OD): δ 7.37 (1H, d, J = 9.1 Hz, H-6), 7.20 (1H,
3
in distilled water and successively partitioned with n- d, J = 16.4 Hz, H-7), 6.74 (1H, d, J = 16.4 Hz, H-7'), 6.40
Hexane, EtOAc, and n-BuOH. Silica gel column chroma- (2H, d, J = 2.1 Hz, H-2', 6'), 6.23 (1H, d, J = 2.3 Hz, H-3),
tography (CC) of EtOAc fraction (78.2 g) was carried out 6.23 (1H, dd, J = 7.6, 2.3 Hz, H-5), 6.04 (1H, t, J = 2.0
using CHCl followed by a mixture of CHCl -MeOH in a
3 3 Hz, H-4'). C-NMR (75 MHz, CD OD): δ 160.2 (C-3'),
13
3
gradient system, and yielded nine subfractions (E1 ~ E9). 159.9 (C-4), 158 (C-2), 142.9 (C-1'), 129.1 (C-6), 127.2
Fraction E4 was subjected to silica gel CC (CHCl - (C-7'), 125.5 (C-7), 118.6 (C-1), 109.9 (C-5), 106.4 (C-2',
MeOH, 50 : 1 → 1 : 1) to give 10 subfrations (E4-1 ~
3
E4-7-8 was purified over HPLC (55% MeOH) to yield (1H, s, H-4'), 6.86 (1H, s, H-7), 6.49 (1H, s, H-2'), 3.79
27.6mg of compound 2. Fraction E5 was separated by (1H, dd, J = 7.4, 5.4 Hz, H-2''), 3.13 (1H, d, J = 16.4, 5.2
MPLC using MeOH-H O gradient (20% - 80% MeOH)
2 Hz, H-1''a), 2.84 (1H, dd, J = 16.4, 7.5 Hz, H-1''b), 1.35
elution to give 20 subfractions (E5-1 ~ E5-20). Fraction (3H, s, H-4''), 1.27 (3H, s, H-5''), xylopyranoside δ 4.89
E5-4 was purified over HPLC (70% MeOH) to yield (1H, d, J = 7.1 Hz, xyl-H1), 3.97 (1H, dd, J = 11.3, 5.2
258.8 mg of compound 3. Fraction E6 was separated by Hz, xyl-H5β), 3.59 (1H, br m, xyl-H4), 3.3 - 3.46 (2H, m,
MPLC using MeOH-H O gradient (30% - 90% MeOH)
2 xyl-H2 and xyl-H3), 3.36 (1H, br s, xyl-H5α). C-NMR 13
elution to afford 19 subfractions (E6-1 ~ E6-19). Fraction (100 MHz, DMSO-d6): δ 161.2 (C-5'), 160.7 (C-3'), 156.9
E6-14 was purified using HPLC (60% MeOH) to yield (C-2), 156.8 (C-7a), 153.5 (C-6), 134.5 (C-1'), 124.9 (C-
30.2 mg of compound 4. Fraction E7 was separated by 3a), 122.7 (C-4), 118.6 (C-5), 107.4 (C-6'), 106.2 (C-4'),
MPLC using MeOH-H O gradient (30% - 80% MeOH)
2 105.9 (C-2'), 103.1 (C-3), 100.5 (C-7), 79 (C-3''), 71.3 (C-
elution and yielded 17.7 mg of compound 5. 2''), 33.2 (C-1''), 26.8 (C-5''), 21.8 (C-4''), xylopyranoside
7,2',4'-Trihydroxyflavanone (1): C H O colorless
15 12 4, δ 103.7 (xyl-C1), 78.5 (xyl-C2), 75.5 (xyl-C3), 71.8 (xyl-
amorphous powder. ESI MS (m/z) : 271 [M-H]−. H- 1
C4), 67.7 (xyl-C5).
NMR (500 MHz, acetone-d6): δ 7.70 (1H, d, J = 8.6 Hz, Moracin M-3'-O-β-D-glucopyranoside (5): C H O , 20 20 9
H-5), 7.29 (1H, d, J = 8.4 Hz, H-6'), 6.53 (1H, dd, J = 8.6, brown amorphous powder. ESI MS (m/z) : 405 [M + H] . +
200 Natural Product Sciences
1
H-NMR (400 MHz, DMSO-d6) : δ 7.17 (1H, s, H-3),
7.40 (1H, d, J = 8.4 Hz, H-4), 6.75 (1H, dd, J = 8.4, 2.0
Hz, H-5), 6.94 (1H, br s, H-7), 6.97 (1H, br s, H-2'), 6.44
(1H, br s, H-4'), 6.89 (1H, br s, H-6'), glucopyranisode δ
4.63 (1H, d, J = 7.4 Hz, glc-H1), 3.20 - 3.24 (1H, m, glc-
H2), 3.27 - 3.34 (1H, m, glc-H3), 3.20 - 3.24 (1H, m, glc-
H4), 3.27 - 3.34 (1H, m, glc-H5), 3.53 (1H, dd, J = 11.7,
5.8 Hz, glc-H6), 3.75 (1H, dd, J = 11.1, 3.7 Hz, glc-H6).
13
C-NMR (100 MHz, DMSO-d6) : δ 159.0 (C-3'), 158.7
(C-5'), 155.8 (C-6), 155.3 (C-7a), 153.5 (C-2), 131.7 (C-
1'), 121.2 (C-4), 120.7 (C-3a), 112.5 (C-5), 104.7 (C-6'), Fig. Tyrosinase inhibitory effects of total extract and its
1.
103.6 (C-2'), 103.3 (C-4'), 102.1 (C-3), 97.5 (C-7), fractions of Morus bombycis. The concentration of the treated
glucopyranisode δ 101.0 (glc-C1), 73.3 (glc-C2), 76.6 samples was 100 µg/ml. *P < 0.05, significantly different from
the blank reference.
(glc-C3), 69.7 (glc-C4), 77.1 (glc-C5), 60.7 (glc-C6).
Tyrosinase Inhibitory Assay − The total extract, Table 1. Mushroom tyrosinase inhibitory activity of compounds
fractions, and isolated compounds were dissolved in 1 - 5
DMSO, and then diluted to several concentration in 0.1 M Compounds IC50 (µM) SDa
pH 6.8 sodium phosphate buffer. DMSO was added to
make the DMSO concentration of each sample equally 1 5.228 1.079
(final conc. 0.1%). The sample solutions (70 µL) were set 2 0.9724 1.073
on the 96-well plate, followed by the addition of 30 µL of 3 3.66 1.122
mushroom tyrosinase solution (1000 units/mL) and 40 µL 4 61.3 1.087
of 3 mM L-tyrosine solution. 70 µL of 0.1% DMSO- 5 127.5 1.285
buffer solution and 70 µL of kojic acid solution were used Kojic acidb 112.7 1.178
as the blank reference and positive control, respectively. a
SD : Standard deviation. IC50 value is calculated by logC-%inhi-
The absorbance at 490 nm of the reaction mixture bition plot, so SD value is the antilog of standard error of logIC50.
These values mean geometric SD, or a number that you can mul-
(140 µL) was measured using the ELISA reader, and the tiply the mean by or divide the mean into.
mixture was incubated for 10 min at 37 C. After the
o b
Kojic acid : Positive control.
incubation, the absorbance of mixture was measured
again. The inhibition percentage of tyrosinase activity was compounds were identified as 7,2',4'-trihydroxyflavanone
calculated as follows: (1) (Lim et al., 2001), 2',4',2,4,-tetrahydroxychalcone (2)
%inhibition = (A2 − A1) − (B2 − B1) / (A2 − A1) × 100 (Lim et al., 2001), oxyreveratrol (2',4',3,5-tetrahydroxy-
stilbene) (3) (Kanchanapoom et al., 2002), moracinoside
A1 is the absorbance at 490 nm of the blank reference M (4) (Jeong et al., 2009), and moracin M-3'-O-β-D-
at 0 min, and A2 is the absorbance at 490 nm of the blank glucopyranoside (5) (Kanchanapoom et al., 2002) by
at 10 min. B1 is the absorbance at 490 nm of the test comparing the H-, C-NMR and MS spectral data with
1 13
For the isolation of bio-active compounds from Morus 1.12, respectively, which were more potent than that of
bombycis cortex, the inhibitory effects of total extract and positive control, kojic acid. In addition, The inhibitory
the fractions (including n-Hexane, EtOAc, BuOH and effect of compound 2 was shown to be more potent than
water fractions) of this plant on tyrosinase were evaluated. that of compound 3 (oxyresveratrol) reported previously
As shown in Fig. 1, the total extract showed a potent as a major ingredient that contributes to skin whitening
tyrosinase inhibitory activity, and the EtOAc fraction was effect of Morus plants (Shin et al., 1998). To exhibit their
the most potent among the four solvent fractions. EtOAc mechanism of inhibition, we performed kinetic study for
fraction was further subjected to repeated column compounds 1 and 2. As a result, both compounds 1 and 2
chromatography yielded five pure compounds. The isolated were shown to play as competitive inhibitors on
Vol. 17, No. 3, 2011 201
(2009).
Kanchanapoom, T., Suga, K., Kasai, R., Yamasaki, K., Kamel, M. S., and
Mohamed, M. H., Stilbene and 2-Arylbenzofuran Glucosides from the
Rhizomes of Schoenocaulon officinale. Chem. Pharm. Bull., , 863-
50
865 (2002).
Katib, S., Nerya, O., Musa, R., Shmuel, M., Tamir, S., and Vaya, J.,
Chalcones as potent tyrosinase inhibitors : the importance of a 2, 4-
substituted resorcinol moiety. Bioorg. Med. Chem., , 433-441 (2005).
13
Lee, S.H., Choi, S.Y., Kim, H.C., Hwang, J.S., Lee, B.G., Gao, J.J., and
Kim, S.Y., Mulberroside F isolated from the leaves of Morus alba
inhibits melanin biosynthesis. Biol. Pharm. Bull., , 1045-1048 (2002).
25
Lim, S.S., Jung S.H., Ji, J., Shin, K.H., and Keum, S.R., Synthesis of
flavonoids and their effect on aldose reductase and sorbitol
Fig. 3.Lineweaver-Burk plots of compound in mushroom
1
accumulation in streptozotocin-induced diabetic rat tissues. J. Pharm.
tyrosinase assay. Values of absorbance were measured at 490 nm
in the presence of compound (1 µM) ( ■ ), or buffer solution Pharmacol., , 653-668 (2001).
53
with 0.1% DMSO ( ● ), as control. Martínez-Esparza, M., Jiménez-Cervantes, C., Solano, F., Lozano, J.A.,
1
Nerya, O., Musa, R., Khatib, S., Tamir, S., and Vaya, J., Chalcones as
potent tyrosinase inhibitors : the effect of hydroxyl positions and
numbers. Phytochemistry, , 1389-1395 (2004).
65
Shin, N.H., Ryu, S.Y., Choi, E.J., Kang, S.H., Chang, I.M., Min, K.R.,
and Ki, Y.S., Oxyresveratrol as the potent inhibitor on Dopa oxidase
activity of mushroom tyrosinase. Biochem Biophys Res Commun.,
243 , 801-803 (1998).
Siegbahn, P.E., A comparison of the thermodynamics of O-O bond
cleavage for dicoppor complexes in enzymes and synthetic systems. J.
Biol. Inorg. Chem., , 577-585 (2003).
8
Slominski, A., Tobin, D.J., Shibahara, S., and Wortman, J., Melanin
pigmentation in mammalian skin and its hormonal regulation. Phys.
Fig. 4.Lineweaver-Burk plots of compound in mushroom
2 Rev. , 1155-1228 (2004).
84
tyrosinase assay. Values of absorbance were measured at 490 nm Solano, F., Briganti, S., Picardo, M., and Ghanem, G., Hypopigmenting
in the presence of compound (125 nM) ( ▼ ), or buffer solution agents : an updated review on biological, chemical and clinical
with 0.1% DMSO ( ● ), as control.
2
Van Gelder, C.W., Flurkey, W.H., and Wichers, H.J., Sequence and
structural features ofplantand fungal tyrosinases. Phytochemistry, ,
45